175 related articles for article (PubMed ID: 24738485)
1. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg.
Chen X; Liu Y; Wang L; Liu Y; Zhang W; Fan B; Ma X; Yuan Q; Ma G; Su Z
Mol Pharm; 2014 Jun; 11(6):1772-84. PubMed ID: 24738485
[TBL] [Abstract][Full Text] [Related]
2. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
Saini V; Jain V; Sudheesh MS; Dixit S; Gaur RL; Sahoo MK; Joseph SK; Verma SK; Jaganathan KS; Murthy PK; Kohli D
J Drug Target; 2010 Apr; 18(3):212-22. PubMed ID: 19883203
[TBL] [Abstract][Full Text] [Related]
4. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
[TBL] [Abstract][Full Text] [Related]
5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
6. Potential Hepatitis B Vaccine Formulation Prepared by Uniform-Sized Lipid Hybrid PLA Microparticles with Adsorbed Hepatitis B Surface Antigen.
Liu Q; Chen X; Jia J; Lu T; Yang T; Wang L
Mol Pharm; 2018 Nov; 15(11):5227-5235. PubMed ID: 30350642
[TBL] [Abstract][Full Text] [Related]
7. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
8. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.
Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z
Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
[TBL] [Abstract][Full Text] [Related]
12. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
13. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
Thomas C; Gupta V; Ahsan F
Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.
Pandit S; Cevher E; Zariwala MG; Somavarapu S; Alpar HO
J Microencapsul; 2007 Sep; 24(6):539-52. PubMed ID: 17654174
[TBL] [Abstract][Full Text] [Related]
15. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
16. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.
Ataman-Onal Y; Munier S; Ganée A; Terrat C; Durand PY; Battail N; Martinon F; Le Grand R; Charles MH; Delair T; Verrier B
J Control Release; 2006 May; 112(2):175-85. PubMed ID: 16563545
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
18. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.
Stivaktakis N; Nikou K; Panagi Z; Beletsi A; Leondiadis L; Avgoustakis K
J Biomed Mater Res A; 2005 Jun; 73(3):332-8. PubMed ID: 15793820
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.
Aline F; Brand D; Pierre J; Roingeard P; Séverine M; Verrier B; Dimier-Poisson I
Vaccine; 2009 Aug; 27(38):5284-91. PubMed ID: 19450633
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
Thomas C; Rawat A; Hope-Weeks L; Ahsan F
Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
